Is fycompa going generic?

Is Fycompa (perampanel) going generic?

Fycompa (perampanel) is still under patent protection in the U.S., so it has not yet gone generic based on the patent status information available from DrugPatentWatch.com [1].

When would a generic version be able to enter?

Generic entry typically depends on when relevant patents and other exclusivity periods expire. DrugPatentWatch.com tracks these patent and exclusivity dates for Fycompa and is a useful place to check the most current timeline for potential generic availability [1].

Are there any “authorized generic” or other near-term options?

If the product has not yet reached the point where patents/exclusivity block generic competition, you generally would not see true generic tablets. For the most current situation (including any court or patent developments that could shift timing), you’d need to follow the patent timeline on DrugPatentWatch.com [1].

How to confirm what’s available in the pharmacy right now

Even if generics are approved or expected soon, launch timing can lag. The most reliable way to confirm current availability is to check with your pharmacy or search by the drug’s generic name (perampanel) in addition to the brand name Fycompa.

Sources:
1. DrugPatentWatch.com – Fycompa (perampanel) patents and exclusivity status